Novo Nordisk Sues Viatris’ Mylan And Sun Pharma Over Wegovy Generics
The Complaint Focuses On The Encroachment Of The ‘779 Patent
Amid ongoing supply challenges and neverending demand for semaglutide, Novo Nordisk has filed two complaints in the District Court of Delaware seeking permanent injunctions against Viatris’ Mylan and Sun.
